Request for Covid-19 Impact Assessment of this Report
The United States Terbinafine (Lamisil) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Terbinafine (Lamisil) market, reaching US$ million by the year 2028. As for the Europe Terbinafine (Lamisil) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Terbinafine (Lamisil) players cover Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, and TEVA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Terbinafine (Lamisil) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
External Use
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Fungal Infection Of The Skin And Mucous Membrane
Onychomycosis
Bronchial Asthma
Gynecological Anti-Infection Preparation
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Terbinafine (Lamisil) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Terbinafine (Lamisil) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Terbinafine (Lamisil) by Country/Region, 2017, 2022 & 2028
2.2 Terbinafine (Lamisil) Segment by Type
2.2.1 Oral
2.2.2 External Use
2.3 Terbinafine (Lamisil) Sales by Type
2.3.1 Global Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
2.3.2 Global Terbinafine (Lamisil) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Terbinafine (Lamisil) Sale Price by Type (2017-2022)
2.4 Terbinafine (Lamisil) Segment by Application
2.4.1 Fungal Infection Of The Skin And Mucous Membrane
2.4.2 Onychomycosis
2.4.3 Bronchial Asthma
2.4.4 Gynecological Anti-Infection Preparation
2.4.5 Other
2.5 Terbinafine (Lamisil) Sales by Application
2.5.1 Global Terbinafine (Lamisil) Sale Market Share by Application (2017-2022)
2.5.2 Global Terbinafine (Lamisil) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Terbinafine (Lamisil) Sale Price by Application (2017-2022)
3 Global Terbinafine (Lamisil) by Company
3.1 Global Terbinafine (Lamisil) Breakdown Data by Company
3.1.1 Global Terbinafine (Lamisil) Annual Sales by Company (2020-2022)
3.1.2 Global Terbinafine (Lamisil) Sales Market Share by Company (2020-2022)
3.2 Global Terbinafine (Lamisil) Annual Revenue by Company (2020-2022)
3.2.1 Global Terbinafine (Lamisil) Revenue by Company (2020-2022)
3.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Company (2020-2022)
3.3 Global Terbinafine (Lamisil) Sale Price by Company
3.4 Key Manufacturers Terbinafine (Lamisil) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Terbinafine (Lamisil) Product Location Distribution
3.4.2 Players Terbinafine (Lamisil) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Terbinafine (Lamisil) by Geographic Region
4.1 World Historic Terbinafine (Lamisil) Market Size by Geographic Region (2017-2022)
4.1.1 Global Terbinafine (Lamisil) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Terbinafine (Lamisil) Annual Revenue by Geographic Region
4.2 World Historic Terbinafine (Lamisil) Market Size by Country/Region (2017-2022)
4.2.1 Global Terbinafine (Lamisil) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Terbinafine (Lamisil) Annual Revenue by Country/Region
4.3 Americas Terbinafine (Lamisil) Sales Growth
4.4 APAC Terbinafine (Lamisil) Sales Growth
4.5 Europe Terbinafine (Lamisil) Sales Growth
4.6 Middle East & Africa Terbinafine (Lamisil) Sales Growth
5 Americas
5.1 Americas Terbinafine (Lamisil) Sales by Country
5.1.1 Americas Terbinafine (Lamisil) Sales by Country (2017-2022)
5.1.2 Americas Terbinafine (Lamisil) Revenue by Country (2017-2022)
5.2 Americas Terbinafine (Lamisil) Sales by Type
5.3 Americas Terbinafine (Lamisil) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Terbinafine (Lamisil) Sales by Region
6.1.1 APAC Terbinafine (Lamisil) Sales by Region (2017-2022)
6.1.2 APAC Terbinafine (Lamisil) Revenue by Region (2017-2022)
6.2 APAC Terbinafine (Lamisil) Sales by Type
6.3 APAC Terbinafine (Lamisil) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Terbinafine (Lamisil) by Country
7.1.1 Europe Terbinafine (Lamisil) Sales by Country (2017-2022)
7.1.2 Europe Terbinafine (Lamisil) Revenue by Country (2017-2022)
7.2 Europe Terbinafine (Lamisil) Sales by Type
7.3 Europe Terbinafine (Lamisil) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Terbinafine (Lamisil) by Country
8.1.1 Middle East & Africa Terbinafine (Lamisil) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2017-2022)
8.2 Middle East & Africa Terbinafine (Lamisil) Sales by Type
8.3 Middle East & Africa Terbinafine (Lamisil) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Terbinafine (Lamisil)
10.3 Manufacturing Process Analysis of Terbinafine (Lamisil)
10.4 Industry Chain Structure of Terbinafine (Lamisil)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Terbinafine (Lamisil) Distributors
11.3 Terbinafine (Lamisil) Customer
12 World Forecast Review for Terbinafine (Lamisil) by Geographic Region
12.1 Global Terbinafine (Lamisil) Market Size Forecast by Region
12.1.1 Global Terbinafine (Lamisil) Forecast by Region (2023-2028)
12.1.2 Global Terbinafine (Lamisil) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Terbinafine (Lamisil) Forecast by Type
12.7 Global Terbinafine (Lamisil) Forecast by Application
13 Key Players Analysis
13.1 Perrigo
13.1.1 Perrigo Company Information
13.1.2 Perrigo Terbinafine (Lamisil) Product Offered
13.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Perrigo Main Business Overview
13.1.5 Perrigo Latest Developments
13.2 Novartis Pharmaceuticals Corporation
13.2.1 Novartis Pharmaceuticals Corporation Company Information
13.2.2 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Offered
13.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Pharmaceuticals Corporation Main Business Overview
13.2.5 Novartis Pharmaceuticals Corporation Latest Developments
13.3 Gokul Pharma
13.3.1 Gokul Pharma Company Information
13.3.2 Gokul Pharma Terbinafine (Lamisil) Product Offered
13.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Gokul Pharma Main Business Overview
13.3.5 Gokul Pharma Latest Developments
13.4 TEVA
13.4.1 TEVA Company Information
13.4.2 TEVA Terbinafine (Lamisil) Product Offered
13.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 TEVA Main Business Overview
13.4.5 TEVA Latest Developments
13.5 Mylan Pharmaceuticals
13.5.1 Mylan Pharmaceuticals Company Information
13.5.2 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Offered
13.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan Pharmaceuticals Main Business Overview
13.5.5 Mylan Pharmaceuticals Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Terbinafine (Lamisil) Product Offered
13.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sivem Pharmaceuticals
13.7.1 Sivem Pharmaceuticals Company Information
13.7.2 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Offered
13.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sivem Pharmaceuticals Main Business Overview
13.7.5 Sivem Pharmaceuticals Latest Developments
13.8 Apotex Corporation
13.8.1 Apotex Corporation Company Information
13.8.2 Apotex Corporation Terbinafine (Lamisil) Product Offered
13.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Apotex Corporation Main Business Overview
13.8.5 Apotex Corporation Latest Developments
13.9 Auro Pharma Inc
13.9.1 Auro Pharma Inc Company Information
13.9.2 Auro Pharma Inc Terbinafine (Lamisil) Product Offered
13.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Auro Pharma Inc Main Business Overview
13.9.5 Auro Pharma Inc Latest Developments
13.10 PLIVA
13.10.1 PLIVA Company Information
13.10.2 PLIVA Terbinafine (Lamisil) Product Offered
13.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 PLIVA Main Business Overview
13.10.5 PLIVA Latest Developments
13.11 Jamp Pharma Corporation
13.11.1 Jamp Pharma Corporation Company Information
13.11.2 Jamp Pharma Corporation Terbinafine (Lamisil) Product Offered
13.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jamp Pharma Corporation Main Business Overview
13.11.5 Jamp Pharma Corporation Latest Developments
13.12 Nu Pharm
13.12.1 Nu Pharm Company Information
13.12.2 Nu Pharm Terbinafine (Lamisil) Product Offered
13.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Nu Pharm Main Business Overview
13.12.5 Nu Pharm Latest Developments
13.13 Codal Synto
13.13.1 Codal Synto Company Information
13.13.2 Codal Synto Terbinafine (Lamisil) Product Offered
13.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Codal Synto Main Business Overview
13.13.5 Codal Synto Latest Developments
13.14 Qd Pharmaceuticals
13.14.1 Qd Pharmaceuticals Company Information
13.14.2 Qd Pharmaceuticals Terbinafine (Lamisil) Product Offered
13.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Qd Pharmaceuticals Main Business Overview
13.14.5 Qd Pharmaceuticals Latest Developments
13.15 Pharmel Inc
13.15.1 Pharmel Inc Company Information
13.15.2 Pharmel Inc Terbinafine (Lamisil) Product Offered
13.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Pharmel Inc Main Business Overview
13.15.5 Pharmel Inc Latest Developments
13.16 Smaart Pharmaceutticals
13.16.1 Smaart Pharmaceutticals Company Information
13.16.2 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Offered
13.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Smaart Pharmaceutticals Main Business Overview
13.16.5 Smaart Pharmaceutticals Latest Developments
13.17 Qilu Pharmaceutical
13.17.1 Qilu Pharmaceutical Company Information
13.17.2 Qilu Pharmaceutical Terbinafine (Lamisil) Product Offered
13.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Qilu Pharmaceutical Main Business Overview
13.17.5 Qilu Pharmaceutical Latest Developments
13.18 Qingdao Jinfeng Pharmaceutical
13.18.1 Qingdao Jinfeng Pharmaceutical Company Information
13.18.2 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Offered
13.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Qingdao Jinfeng Pharmaceutical Main Business Overview
13.18.5 Qingdao Jinfeng Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Terbinafine (Lamisil) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Terbinafine (Lamisil) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of External Use
Table 5. Global Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 6. Global Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
Table 7. Global Terbinafine (Lamisil) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Terbinafine (Lamisil) Revenue Market Share by Type (2017-2022)
Table 9. Global Terbinafine (Lamisil) Sale Price by Type (2017-2022) & (US$/G)
Table 10. Global Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 11. Global Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Table 12. Global Terbinafine (Lamisil) Revenue by Application (2017-2022)
Table 13. Global Terbinafine (Lamisil) Revenue Market Share by Application (2017-2022)
Table 14. Global Terbinafine (Lamisil) Sale Price by Application (2017-2022) & (US$/G)
Table 15. Global Terbinafine (Lamisil) Sales by Company (2020-2022) & (KG)
Table 16. Global Terbinafine (Lamisil) Sales Market Share by Company (2020-2022)
Table 17. Global Terbinafine (Lamisil) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Terbinafine (Lamisil) Revenue Market Share by Company (2020-2022)
Table 19. Global Terbinafine (Lamisil) Sale Price by Company (2020-2022) & (US$/G)
Table 20. Key Manufacturers Terbinafine (Lamisil) Producing Area Distribution and Sales Area
Table 21. Players Terbinafine (Lamisil) Products Offered
Table 22. Terbinafine (Lamisil) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Terbinafine (Lamisil) Sales by Geographic Region (2017-2022) & (KG)
Table 26. Global Terbinafine (Lamisil) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Terbinafine (Lamisil) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Terbinafine (Lamisil) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Terbinafine (Lamisil) Sales by Country/Region (2017-2022) & (KG)
Table 30. Global Terbinafine (Lamisil) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Terbinafine (Lamisil) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Terbinafine (Lamisil) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 34. Americas Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 35. Americas Terbinafine (Lamisil) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 37. Americas Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 38. Americas Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
Table 39. Americas Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 40. Americas Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Table 41. APAC Terbinafine (Lamisil) Sales by Region (2017-2022) & (KG)
Table 42. APAC Terbinafine (Lamisil) Sales Market Share by Region (2017-2022)
Table 43. APAC Terbinafine (Lamisil) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Terbinafine (Lamisil) Revenue Market Share by Region (2017-2022)
Table 45. APAC Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 46. APAC Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
Table 47. APAC Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 48. APAC Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Table 49. Europe Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 50. Europe Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 51. Europe Terbinafine (Lamisil) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 53. Europe Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 54. Europe Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
Table 55. Europe Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 56. Europe Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 58. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 62. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 64. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Terbinafine (Lamisil)
Table 66. Key Market Challenges & Risks of Terbinafine (Lamisil)
Table 67. Key Industry Trends of Terbinafine (Lamisil)
Table 68. Terbinafine (Lamisil) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Terbinafine (Lamisil) Distributors List
Table 71. Terbinafine (Lamisil) Customer List
Table 72. Global Terbinafine (Lamisil) Sales Forecast by Region (2023-2028) & (KG)
Table 73. Global Terbinafine (Lamisil) Sales Market Forecast by Region
Table 74. Global Terbinafine (Lamisil) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Terbinafine (Lamisil) Sales Forecast by Country (2023-2028) & (KG)
Table 77. Americas Terbinafine (Lamisil) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Terbinafine (Lamisil) Sales Forecast by Region (2023-2028) & (KG)
Table 79. APAC Terbinafine (Lamisil) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Terbinafine (Lamisil) Sales Forecast by Country (2023-2028) & (KG)
Table 81. Europe Terbinafine (Lamisil) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Terbinafine (Lamisil) Sales Forecast by Country (2023-2028) & (KG)
Table 83. Middle East & Africa Terbinafine (Lamisil) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Terbinafine (Lamisil) Sales Forecast by Type (2023-2028) & (KG)
Table 85. Global Terbinafine (Lamisil) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Terbinafine (Lamisil) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Terbinafine (Lamisil) Sales Forecast by Application (2023-2028) & (KG)
Table 89. Global Terbinafine (Lamisil) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Terbinafine (Lamisil) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Perrigo Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 93. Perrigo Terbinafine (Lamisil) Product Offered
Table 94. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 95. Perrigo Main Business
Table 96. Perrigo Latest Developments
Table 97. Novartis Pharmaceuticals Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Offered
Table 99. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 100. Novartis Pharmaceuticals Corporation Main Business
Table 101. Novartis Pharmaceuticals Corporation Latest Developments
Table 102. Gokul Pharma Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 103. Gokul Pharma Terbinafine (Lamisil) Product Offered
Table 104. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 105. Gokul Pharma Main Business
Table 106. Gokul Pharma Latest Developments
Table 107. TEVA Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 108. TEVA Terbinafine (Lamisil) Product Offered
Table 109. TEVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 110. TEVA Main Business
Table 111. TEVA Latest Developments
Table 112. Mylan Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan Pharmaceuticals Terbinafine (Lamisil) Product Offered
Table 114. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 115. Mylan Pharmaceuticals Main Business
Table 116. Mylan Pharmaceuticals Latest Developments
Table 117. Pfizer Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 118. Pfizer Terbinafine (Lamisil) Product Offered
Table 119. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. Sivem Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 123. Sivem Pharmaceuticals Terbinafine (Lamisil) Product Offered
Table 124. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 125. Sivem Pharmaceuticals Main Business
Table 126. Sivem Pharmaceuticals Latest Developments
Table 127. Apotex Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 128. Apotex Corporation Terbinafine (Lamisil) Product Offered
Table 129. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 130. Apotex Corporation Main Business
Table 131. Apotex Corporation Latest Developments
Table 132. Auro Pharma Inc Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 133. Auro Pharma Inc Terbinafine (Lamisil) Product Offered
Table 134. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 135. Auro Pharma Inc Main Business
Table 136. Auro Pharma Inc Latest Developments
Table 137. PLIVA Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 138. PLIVA Terbinafine (Lamisil) Product Offered
Table 139. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 140. PLIVA Main Business
Table 141. PLIVA Latest Developments
Table 142. Jamp Pharma Corporation Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 143. Jamp Pharma Corporation Terbinafine (Lamisil) Product Offered
Table 144. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 145. Jamp Pharma Corporation Main Business
Table 146. Jamp Pharma Corporation Latest Developments
Table 147. Nu Pharm Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 148. Nu Pharm Terbinafine (Lamisil) Product Offered
Table 149. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 150. Nu Pharm Main Business
Table 151. Nu Pharm Latest Developments
Table 152. Codal Synto Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 153. Codal Synto Terbinafine (Lamisil) Product Offered
Table 154. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 155. Codal Synto Main Business
Table 156. Codal Synto Latest Developments
Table 157. Qd Pharmaceuticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 158. Qd Pharmaceuticals Terbinafine (Lamisil) Product Offered
Table 159. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 160. Qd Pharmaceuticals Main Business
Table 161. Qd Pharmaceuticals Latest Developments
Table 162. Pharmel Inc Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 163. Pharmel Inc Terbinafine (Lamisil) Product Offered
Table 164. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 165. Pharmel Inc Main Business
Table 166. Pharmel Inc Latest Developments
Table 167. Smaart Pharmaceutticals Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 168. Smaart Pharmaceutticals Terbinafine (Lamisil) Product Offered
Table 169. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 170. Smaart Pharmaceutticals Main Business
Table 171. Smaart Pharmaceutticals Latest Developments
Table 172. Qilu Pharmaceutical Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 173. Qilu Pharmaceutical Terbinafine (Lamisil) Product Offered
Table 174. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 175. Qilu Pharmaceutical Main Business
Table 176. Qilu Pharmaceutical Latest Developments
Table 177. Qingdao Jinfeng Pharmaceutical Basic Information, Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 178. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Offered
Table 179. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 180. Qingdao Jinfeng Pharmaceutical Main Business
Table 181. Qingdao Jinfeng Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Terbinafine (Lamisil)
Figure 2. Terbinafine (Lamisil) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Terbinafine (Lamisil) Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Terbinafine (Lamisil) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Terbinafine (Lamisil) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of External Use
Figure 11. Global Terbinafine (Lamisil) Sales Market Share by Type in 2021
Figure 12. Global Terbinafine (Lamisil) Revenue Market Share by Type (2017-2022)
Figure 13. Terbinafine (Lamisil) Consumed in Fungal Infection Of The Skin And Mucous Membrane
Figure 14. Global Terbinafine (Lamisil) Market: Fungal Infection Of The Skin And Mucous Membrane (2017-2022) & (KG)
Figure 15. Terbinafine (Lamisil) Consumed in Onychomycosis
Figure 16. Global Terbinafine (Lamisil) Market: Onychomycosis (2017-2022) & (KG)
Figure 17. Terbinafine (Lamisil) Consumed in Bronchial Asthma
Figure 18. Global Terbinafine (Lamisil) Market: Bronchial Asthma (2017-2022) & (KG)
Figure 19. Terbinafine (Lamisil) Consumed in Gynecological Anti-Infection Preparation
Figure 20. Global Terbinafine (Lamisil) Market: Gynecological Anti-Infection Preparation (2017-2022) & (KG)
Figure 21. Terbinafine (Lamisil) Consumed in Other
Figure 22. Global Terbinafine (Lamisil) Market: Other (2017-2022) & (KG)
Figure 23. Global Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Figure 24. Global Terbinafine (Lamisil) Revenue Market Share by Application in 2021
Figure 25. Terbinafine (Lamisil) Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Terbinafine (Lamisil) Revenue Market Share by Company in 2021
Figure 27. Global Terbinafine (Lamisil) Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Terbinafine (Lamisil) Revenue Market Share by Geographic Region in 2021
Figure 29. Global Terbinafine (Lamisil) Sales Market Share by Region (2017-2022)
Figure 30. Global Terbinafine (Lamisil) Revenue Market Share by Country/Region in 2021
Figure 31. Americas Terbinafine (Lamisil) Sales 2017-2022 (KG)
Figure 32. Americas Terbinafine (Lamisil) Revenue 2017-2022 ($ Millions)
Figure 33. APAC Terbinafine (Lamisil) Sales 2017-2022 (KG)
Figure 34. APAC Terbinafine (Lamisil) Revenue 2017-2022 ($ Millions)
Figure 35. Europe Terbinafine (Lamisil) Sales 2017-2022 (KG)
Figure 36. Europe Terbinafine (Lamisil) Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Terbinafine (Lamisil) Sales 2017-2022 (KG)
Figure 38. Middle East & Africa Terbinafine (Lamisil) Revenue 2017-2022 ($ Millions)
Figure 39. Americas Terbinafine (Lamisil) Sales Market Share by Country in 2021
Figure 40. Americas Terbinafine (Lamisil) Revenue Market Share by Country in 2021
Figure 41. United States Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Terbinafine (Lamisil) Sales Market Share by Region in 2021
Figure 46. APAC Terbinafine (Lamisil) Revenue Market Share by Regions in 2021
Figure 47. China Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Terbinafine (Lamisil) Sales Market Share by Country in 2021
Figure 54. Europe Terbinafine (Lamisil) Revenue Market Share by Country in 2021
Figure 55. Germany Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country in 2021
Figure 62. Egypt Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Terbinafine (Lamisil) Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Terbinafine (Lamisil) in 2021
Figure 68. Manufacturing Process Analysis of Terbinafine (Lamisil)
Figure 69. Industry Chain Structure of Terbinafine (Lamisil)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...